Houttuynia cordata Polysaccharide Alleviates Hepatic Ischemia-Reperfusion Injury by Regulating Macrophage Polarization via Inhibiting the TLR4/NF-κB Signaling Pathway
<b>Background:</b> Hepatic ischemia-reperfusion injury (HIRI) is a major complication in liver surgery with limited therapeutic options. <i>Houttuynia cordata</i> polysaccharide (HCP), a key bioactive component of the traditional anti-inflammatory herb, has demonstrated immunomodulatory potential, but its effect on HIRI remains unclear. <b>Methods:</b> A murine model of 70% hepatic ischemia for 60 min followed by reperfusion was established. Mice were administered low-dose (50 mg/kg) or high-dose (100 mg/kg) HCP or the positive control N-acetylcysteine (150 mg/kg). Liver injury was assessed by serum ALT/AST levels, histopathology, oxidative stress markers, and inflammatory cytokines. Macrophage polarization and the TLR4/NF-κB pathway were analyzed using flow cytometry, qPCR, and Western blot. The TLR4 inhibitor TAK-242 was used for reverse validation, and molecular docking was performed to predict HCP binding to the TLR4/MD-2 complex. <b>Results:</b> HCP significantly attenuated HIRI-induced liver injury, as shown by reduced ALT/AST, improved histopathological scores, decreased MDA, increased SOD, and lower TNF-α and IL-6 levels. Mechanistically, HCP promoted a shift from M1 to M2 macrophage polarization, with increased CD206<sup>+</sup> cells and Arg-1/IL-10 expression and decreased CD86<sup>+</sup> cells and iNOS/IL-1β expression. HCP also suppressed TLR4/MyD88/NF-κB pathway activation, inhibiting NF-κB p65 phosphorylation and nuclear translocation. These protective effects were largely reversed by TAK-242 in vivo and in vitro. Molecular docking indicated stable binding between HCP and TLR4/MD-2. <b>Conclusions:</b> HCP protects against HIRI by targeting TLR4 to inhibit NF-κB signaling, thereby reprogramming macrophage polarization toward the M2 phenotype and alleviating inflammation and oxidative stress. These findings highlight HCP as a promising natural agent for HIRI intervention.
Authors
- Yujie Zhou
- Qiangmin Qiu
- Shusen Zheng (ORCID: https://orcid.org/0000-0003-1459-8261)
- Zhan Chen (ORCID: https://orcid.org/0000-0002-5542-675X)
- Bo Yu
- Tao Qiu
- Jiangqiao Zhou
- Jiefu Zhu
- Dalin He
- Xiaoxiong Ma
- Tianyu Wang
- Zhongbao Chen
Institutions
- Wuhan University (CN)
- Blood Center of Zhejiang Province (CN)
- Renmin Hospital of Wuhan University (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2026-02-14
- DOI
- https://doi.org/10.3390/biomedicines14020433
- Primary Topic
- Nephrotoxicity and Medicinal Plants
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Wuhan University
- Renmin Hospital of Wuhan University